These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8022741)
21. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy. Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376 [TBL] [Abstract][Full Text] [Related]
25. Potential mechanisms of resistance to the modern fluorinated 4-quinolones. Lewin CS; Allen RA; Amyes SG J Med Microbiol; 1990 Mar; 31(3):153-62. PubMed ID: 2156074 [No Abstract] [Full Text] [Related]
26. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation]. Martínez-Martínez L; Calvo J Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927 [TBL] [Abstract][Full Text] [Related]
27. An explicit model for bacterial resistance: application to beta-lactam antibiotics. Waley SG Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188 [TBL] [Abstract][Full Text] [Related]
28. Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. Denyer SP; Maillard JY J Appl Microbiol; 2002; 92 Suppl():35S-45S. PubMed ID: 12000611 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials. Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303 [TBL] [Abstract][Full Text] [Related]
32. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections]. Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429 [TBL] [Abstract][Full Text] [Related]
33. Breaching the Barrier: Quantifying Antibiotic Permeability across Gram-negative Bacterial Membranes. Cama J; Henney AM; Winterhalter M J Mol Biol; 2019 Aug; 431(18):3531-3546. PubMed ID: 30959052 [TBL] [Abstract][Full Text] [Related]
34. [The molecular organization of the bacterial outer membrane and its penetration by antibiotics with beta-lactam and aminoglycoside structures]. Griaznova NS; Subbotina NA Antibiot Khimioter; 1989 Dec; 34(12):925-32. PubMed ID: 2483497 [No Abstract] [Full Text] [Related]
35. Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance. Crandon JL; Kuti JL; Jones RN; Nicolau DP Ann Pharmacother; 2009 Feb; 43(2):220-7. PubMed ID: 19193582 [TBL] [Abstract][Full Text] [Related]
36. Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria. Lambert PA J Appl Microbiol; 2002; 92 Suppl():46S-54S. PubMed ID: 12000612 [TBL] [Abstract][Full Text] [Related]
37. [Membrane permeability and antibiotic resistance in bacteria]. Braun V Naturwissenschaften; 1977 Mar; 64(3):126-32. PubMed ID: 321973 [TBL] [Abstract][Full Text] [Related]
38. Physical insights into permeation of and resistance to antibiotics in bacteria. Ceccarelli M; Ruggerone P Curr Drug Targets; 2008 Sep; 9(9):779-88. PubMed ID: 18781923 [TBL] [Abstract][Full Text] [Related]
40. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group. Spencer RC Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]